Novocure Exec’s “Sell‑to‑Cover” Trade: Routine Tax Move, No Signal of Panic【Financial Flash】
Novocure insider trade: Puri Michal Nath’s tax‑cover sale is routine, not a warning – investors learn what the move means for the biotech’s future.
3 minutes to read